CD133 Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Product Specifications
Background
May play a role in cell differentiation, proliferation and apoptosis (PubMed:24556617) . Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner (PubMed:20818439) .
Synonyms
AC133; Antigen AC133; Hematopoietic stem cell antigen; hProminin; PROM1; Prominin I; Prominin 1; Prominin1; Prominin-1; Prominin like protein 1 precursor; Prominin mouse like 1; prominin1; PROML1; CD133; CORD12; MCDR2; MSTP061; PROML1; RP41; STGD4.
Gene ID
8842
Swiss Prot
O43490
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse
Immunogen
508-552/865
Target
CD133
Clonality
Polyclonal
Isotype
IgG
Conjugation
AbBy Fluor™ 647
Source
KLH conjugated synthetic peptide derived from human CD133
Applications
WB, FCM, IF (IHC-P)
Purification
Purified by Protein A.
Excitation Emission
650nm/665nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), FCM (1:20-100), IF (IHC-P) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
8842
Predicted Cross Reactivity
Rat
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1880832-01 0.05 mg
Anti-CD79B (polatuzumab biosimilar) antibody, Rabbit IgG Chimeric mAb
Ask
View Details 
MBS1880832-02 0.1 mg
Anti-CD79B (polatuzumab biosimilar) antibody, Rabbit IgG Chimeric mAb
Ask
View Details MBS1880832-03 5x 0.1 mg
Anti-CD79B (polatuzumab biosimilar) antibody, Rabbit IgG Chimeric mAb
Ask
View Details 
